News
12 Million Americans Have Undesired Submental Skin Laxity, 75% Do Not Believe Existing Treatment Options Can Meet Their Needs
PLEASANTON, CA – August 25, 2021 – Recros Medica, Inc. today shared insights from the largest consumer market research survey of Americans with loose skin
Recros Medica Adds Aesthetic Medical Device Executives Charlie Huiner and Mitch Levinson to Board of Directors
SAN DIEGO, CA – October 20, 2020 – Recros Medica, Inc. today announced the addition of Charlie Huiner and Mitch Levinson to the company’s Board
Recros Medica Closes $14 Million Series A Financing
Recros Medica, Inc. today announced the closing of a $14 million Series A preferred stock financing.
FDA Accepts Recros Medica De Novo Submission for Nuvellus Focal Contouring System
Recros Medica, Inc. announced today that its de novo regulatory submission for the Nuvellus™ Focal Contouring System has been accepted for review by the US Food and Drug Administration (FDA). Nuvellus™, which utilizes the company’s proprietary Rotational Fractional Resection (RFR) technology, may provide medical aesthetic physicians a minimally-invasive single treatment option to improve submental (neck and jowl) contouring.
Recros Medica Showcases Interim Data on Rotational Fractional Resection Technology at 2018 ASDS
SAN DIEGO, Oct. 9, 2018 /PRNewswire/ — Recros Medica, Inc. announced today it will showcase its Rotational Fractional Resection (RFR) platform at the 2018 American
Recros Medica Unveils the Nuvellus Brand for Its Novel Rotational Fractional Resection Technology
SAN DIEGO, CA, September 27, 2018 – Recros Medica, Inc., an aesthetic medical device company focused on developing devices to reduce skin laxity and improve
Recros Medica Announces New Patent Issued by USPTO
SAN DIEGO, June 19, 2018 /PRNewswire/ — Recros Medica, Inc., an aesthetic medical device company focused on developing devices to reduce skin laxity and improve focal contouring through
Recros Medica Closes $9M Financing, Strengthens Board
SAN DIEGO, CA, January 4, 2018 – Recros Medica, Inc., a development stage medical aesthetic device company focused on reducing skin laxity and focal contouring,
Recros Medica Appoints Thomas A. Albright as President and CEO
SAN DIEGO, CA, September 18, 2017 – Recros Medica, Inc., a development stage medical aesthetic device company focused on reducing skin laxity and focal contouring,